Growth Metrics

AtriCure (ATRC) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $635.4 million.

  • AtriCure's Liabilities and Shareholders Equity rose 331.25% to $635.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 113.11%. This contributed to the annual value of $609.3 million for FY2024, which is 74.99% down from last year.
  • According to the latest figures from Q3 2025, AtriCure's Liabilities and Shareholders Equity is $635.4 million, which was up 331.25% from $608.8 million recorded in Q2 2025.
  • AtriCure's Liabilities and Shareholders Equity's 5-year high stood at $701.1 million during Q2 2021, with a 5-year trough of $581.9 million in Q3 2022.
  • In the last 5 years, AtriCure's Liabilities and Shareholders Equity had a median value of $600.3 million in 2023 and averaged $611.0 million.
  • As far as peak fluctuations go, AtriCure's Liabilities and Shareholders Equity skyrocketed by 3262.4% in 2021, and later tumbled by 1641.93% in 2022.
  • Over the past 5 years, AtriCure's Liabilities and Shareholders Equity (Quarter) stood at $615.3 million in 2021, then decreased by 4.85% to $585.4 million in 2022, then rose by 4.87% to $613.9 million in 2023, then fell by 0.75% to $609.3 million in 2024, then grew by 4.29% to $635.4 million in 2025.
  • Its Liabilities and Shareholders Equity was $635.4 million in Q3 2025, compared to $608.8 million in Q2 2025 and $591.6 million in Q1 2025.